Shares of Zevia PBC (NYSE:ZVIA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $4.4250.
ZVIA has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zevia PBC in a research report on Monday, April 20th. Telsey Advisory Group cut their price target on Zevia PBC from $6.00 to $5.00 and set an “outperform” rating on the stock in a research note on Thursday, February 26th.
Get Our Latest Analysis on ZVIA
Insiders Place Their Bets
Hedge Funds Weigh In On Zevia PBC
Large investors have recently added to or reduced their stakes in the company. Divisadero Street Capital Management LP increased its holdings in Zevia PBC by 90.6% during the 3rd quarter. Divisadero Street Capital Management LP now owns 6,159,362 shares of the company’s stock worth $16,753,000 after purchasing an additional 2,928,382 shares in the last quarter. Ghisallo Capital Management LLC grew its holdings in shares of Zevia PBC by 265.1% in the 3rd quarter. Ghisallo Capital Management LLC now owns 1,100,000 shares of the company’s stock valued at $2,992,000 after acquiring an additional 798,700 shares in the last quarter. Jefferies Financial Group Inc. bought a new position in shares of Zevia PBC in the 4th quarter valued at about $4,864,000. Stoic Point Capital Management LLC bought a new position in shares of Zevia PBC in the 1st quarter valued at about $867,000. Finally, R Squared Ltd grew its holdings in shares of Zevia PBC by 228.8% in the 4th quarter. R Squared Ltd now owns 44,012 shares of the company’s stock valued at $102,000 after acquiring an additional 30,627 shares in the last quarter. Institutional investors own 53.21% of the company’s stock.
Zevia PBC Price Performance
NYSE ZVIA opened at $1.60 on Friday. The firm has a market cap of $122.78 million, a PE ratio of -15.95 and a beta of 0.95. Zevia PBC has a one year low of $1.11 and a one year high of $3.66. The stock’s 50 day simple moving average is $1.30 and its 200 day simple moving average is $1.78.
Zevia PBC (NYSE:ZVIA – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.03) EPS for the quarter, hitting analysts’ consensus estimates of ($0.03). The business had revenue of $46.09 million for the quarter, compared to analyst estimates of $40.97 million. Zevia PBC had a negative return on equity of 13.43% and a negative net margin of 4.11%. As a group, equities analysts expect that Zevia PBC will post -0.1 earnings per share for the current year.
About Zevia PBC
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Read More
- Five stocks we like better than Zevia PBC
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
